7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Chen T and Feng X | Cell-based assay strategy for identification of motif-specific RANK signaling pathway inhibitors. | 2006 | Assay Drug Dev Technol | pmid:16945019 |
Schoppet M et al. | Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in atherosclerosis. | 2006 | Atherosclerosis | pmid:16325821 |
Nybo M and Rasmussen LM | Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells. | 2008 | Atherosclerosis | pmid:18490020 |
Fontes JD et al. | Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. | 2013 | Atherosclerosis | pmid:23489346 |
Lommi JI et al. | High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. | 2011 | Atherosclerosis | pmid:21917259 |
Toffoli B et al. | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 2011 | Atherosclerosis | pmid:21679949 |
Shargorodsky M et al. | Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. | 2009 | Atherosclerosis | pmid:19062016 |
Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
Pedersen ER et al. | Serum osteoprotegerin levels and long-term prognosis in patients with stable angina pectoris. | 2010 | Atherosclerosis | pmid:20621297 |
Van Campenhout A and Golledge J | Osteoprotegerin, vascular calcification and atherosclerosis. | 2009 | Atherosclerosis | pmid:19007931 |
Ziegler S et al. | Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. | 2005 | Atherosclerosis | pmid:16115489 |
Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
Vik A et al. | Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. | 2007 | Atherosclerosis | pmid:16620835 |
Dimitrow PP | Aortic valve stenosis as a complex inflammatory-hematological-osteogenic disease. | 2010 | Atherosclerosis | pmid:20864109 |
Ohmori R et al. | Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. | 2006 | Atherosclerosis | pmid:16678184 |
Secchiero P et al. | An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction. | 2010 | Atherosclerosis | pmid:20015493 |
Pal SN et al. | Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. | 2010 | Atherosclerosis | pmid:20004897 |
Asanuma Y et al. | Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. | 2007 | Atherosclerosis | pmid:17570371 |
Golledge J et al. | Relationship between CT anthropometric measurements, adipokines and abdominal aortic calcification. | 2008 | Atherosclerosis | pmid:17675038 |
Ali Z et al. | Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites. | 2009 | Atherosclerosis | pmid:19423112 |
Chang YC and Zhao JH | Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. | 2011 | Aust Dent J | pmid:22126345 |
Ozçaka O et al. | Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. | 2010 | Aust Dent J | pmid:21133939 |
Pereda GO et al. | Inflammatory and bone regulators expression in murine macrophages under exposure of commercial and experimental mineral trioxide aggregate. | 2012 | Aust Dent J | pmid:22924350 |
Curl L and Sampson W | The presence of TNF-alpha and TNFR1 in aseptic root resorption. A preliminary study. | 2011 | Aust Orthod J | pmid:22372265 |
Curl L et al. | A pharmacodynamic investigation into the efficacy of osteoprotegerin during aseptic inflammation. | 2012 | Aust Orthod J | pmid:23304971 |
Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
Zhang D et al. | [Expression of OPG and RANKL at protein level in human periodontal ligament cells and the effect of 1alpha,25(OH)(2) vitamin D(3) on the secretion of OPG protein in vitro]. | 2004 | Beijing Da Xue Xue Bao | pmid:15605102 |
Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
Fan R et al. | [Expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin in chronic apical periodontitis]. | 2008 | Beijing Da Xue Xue Bao | pmid:18278135 |
Cui NH et al. | [Osteoclastic bone destruction and its regulating factors in oral squamous cell carcinoma]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304322 |
Tang XL et al. | [Effect of 17-beta estradiol on the expression of receptor activator of nuclear factor kappaB ligand and osteoprotegerin of human periodontal ligament cells during their osteogenic differentiation]. | 2007 | Beijing Da Xue Xue Bao | pmid:17304327 |
Wang EB et al. | [Histochemical and immunohistochemical double staining for osteolytic related factors in keratocystic odontogenic tumor]. | 2010 | Beijing Da Xue Xue Bao | pmid:20140051 |
Geusens P and Reid D | Newer drug treatments: their effects on fracture prevention. | 2005 | Best Pract Res Clin Rheumatol | pmid:16301192 |
Mogi M and Kondo A | Down-regulation of mTOR leads to up-regulation of osteoprotegerin in bone marrow cells. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19393224 |
Tanaka H et al. | Expression of RANKL/OPG during bone remodeling in vivo. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21771583 |
Chen XW et al. | Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12150965 |
Mukohyama H et al. | The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10777696 |
Lorget F et al. | Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12163011 |
Kobayashi-Sakamoto M et al. | NF-kappaB-dependent induction of osteoprotegerin by Porphyromonas gingivalis in endothelial cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15013432 |
Ishii T et al. | Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15033472 |
Mancini L et al. | Modulation of the effects of osteoprotegerin (OPG) ligand in a human leukemic cell line by OPG and calcitonin. | 2000 | Biochem. Biophys. Res. Commun. | pmid:11118297 |
Kreja L et al. | Mechanical regulation of osteoclastic genes in human osteoblasts. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18243138 |
Hozumi A et al. | Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19324007 |
Rachner TD et al. | 17beta-Estradiol inhibits osteoprotegerin production by the estrogen receptor-alpha-positive human breast cancer cell line MCF-7. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18252198 |
Nakashima T et al. | Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10973797 |
Akiyama T et al. | PEDF regulates osteoclasts via osteoprotegerin and RANKL. | 2010 | Biochem. Biophys. Res. Commun. | pmid:19945427 |
Brändström H et al. | A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054556 |
Wittrant Y et al. | Osteoprotegerin differentially regulates protease expression in osteoclast cultures. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054560 |
Makhluf HA et al. | Age-related decline in osteoprotegerin expression by human bone marrow cells cultured in three-dimensional collagen sponges. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10679262 |
Penno H et al. | Osteoprotegerin secretion from prostate cancer is stimulated by cytokines, in vitro. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12054622 |
Fu M et al. | Activation of peroxisome proliferator-activated receptor gamma inhibits osteoprotegerin gene expression in human aortic smooth muscle cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:12056809 |
Schoppet M et al. | TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16288714 |
Chikatsu N et al. | Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10631114 |
Mazière C et al. | Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. | 2013 | Biochem. Biophys. Res. Commun. | pmid:24070606 |
Singh PP et al. | Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22561018 |
Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
Miyamoto A et al. | Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9464281 |
Tomoyasu A et al. | Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9571159 |
Akatsu T et al. | Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9753612 |
Hakeda Y et al. | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9790989 |
Nagai M and Sato N | Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10208850 |
Grundt A et al. | Direct effects of osteoprotegerin on human bone cell metabolism. | 2009 | Biochem. Biophys. Res. Commun. | pmid:19748486 |
Tsukii K et al. | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9610359 |
Mizuno A et al. | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9647741 |
Brändström H et al. | Tumor necrosis factor-alpha and -beta upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703945 |
Son J et al. | cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20599715 |
Vidal ON et al. | Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9703989 |
Brändström H et al. | Regulation of osteoprotegerin mRNA levels by prostaglandin E2 in human bone marrow stroma cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9642127 |
Schoppet M et al. | Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21371424 |
Itonaga I et al. | 1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10529407 |
Nakagawa N et al. | Basic fibroblast growth factor inhibits osteoclast formation induced by 1alpha,25-dihydroxyvitamin D(3) through suppressing the production of osteoclast differentiation factor. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548488 |
Notoya M et al. | Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15474477 |
Nakagawa N et al. | Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10548507 |
Ito H et al. | Hedgehog signaling molecules in bone marrow cells at the initial stage of fracture repair. | 1999 | Biochem. Biophys. Res. Commun. | pmid:10462495 |
Chen TH et al. | Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17331472 |
Murakami T et al. | Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9837778 |
Makiishi-Shimobayashi C et al. | Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11181055 |
Kaneuji T et al. | Mechanisms involved in regulation of osteoclastic differentiation by mechanical stress-loaded osteoblasts. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21459078 |
Kwon OH et al. | The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors. | 2005 | Biochem. Biophys. Res. Commun. | pmid:16083856 |
Théoleyre S et al. | Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16828054 |
Hofbauer LC et al. | Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11162519 |
Brändström H et al. | Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11162596 |
Jacobson A et al. | Vitamin A differentially regulates RANKL and OPG expression in human osteoblasts. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15313187 |
Yano K et al. | Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11594776 |
Pantouli E et al. | Inflammatory cytokines activate p38 MAPK to induce osteoprotegerin synthesis by MG-63 cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15721297 |
Lee ZH and Kim HH | Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12745060 |
Pullisaar H et al. | Simvastatin coating of TiOâ‚‚ scaffold induces osteogenic differentiation of human adipose tissue-derived mesenchymal stem cells. | 2014 | Biochem. Biophys. Res. Commun. | pmid:24704451 |
Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
Tang L et al. | Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16603128 |
Viereck V et al. | Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11855844 |
Yang X et al. | Protein Kinase C is a mediator of the synthesis and secretion of osteoprotegerin in osteoblast-like cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11779130 |
Oue E et al. | CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction. | 2012 | Biochem. Biophys. Res. Commun. | pmid:22771802 |
Boissy P et al. | RANKL induces formation of avian osteoclasts from macrophages but not from macrophage polykaryons. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11606048 |
Park H et al. | Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts. | 2007 | Biochem. Biophys. Res. Commun. | pmid:17222389 |
Bridgham JT and Johnson AL | Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin. | 2003 | Biochem. Biophys. Res. Commun. | pmid:12878204 |
Matayoshi T et al. | Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15649411 |
Yasuhara R et al. | Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. | 2009 | Biochem. J. | pmid:19102726 |
Xu D et al. | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. | 2004 | Biochem. J. | pmid:15250821 |